Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 97251-97300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04679662
EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation
NA
Not yet recruiting
10 participants
Started: Mar 31, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
0 locations
NCT05696470
Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs
N/A
Active, not recruiting
58 participants
Started: Mar 31, 2021 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT04747314
Treating Negative Affect in Low Back Pain Patients
PHASE2/PHASE3
Active, not recruiting
330 participants
Started: Mar 31, 2021 · Completed: Apr 30, 2026
2 conditions
5 sponsors
3 locations
NCT04610021
Prospective i-FactorTM Analysis Fusion Rate and Quality of Life
NA
Not yet recruiting
128 participants
Started: Mar 31, 2021 · Completed: Mar 31, 2027
4 conditions
1 sponsor
1 location
NCT04677205
Molecular Signature From Tumor to Lymph Nodes
N/A
Recruiting
200 participants
Started: Mar 30, 2021 · Completed: Nov 30, 2027
5 conditions
4 sponsors
12 locations
NCT04767568
Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening
NA
Recruiting
400 participants
Started: Mar 30, 2021 · Completed: Sep 30, 2028
1 condition
1 sponsor
3 locations
NCT04798339
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Mar 30, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
2 locations
NCT04830410
The Effects of Carbohydrates in Irritable Bowel Syndrome
NA
Recruiting
70 participants
Started: Mar 30, 2021 · Completed: Mar 31, 2025
1 condition
3 sponsors
1 location
NCT04520932
Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors
NA
Recruiting
82 participants
Started: Mar 30, 2021 · Completed: Apr 30, 2031
2 conditions
1 sponsor
1 location
NCT04671511
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
NA
Recruiting
98 participants
Started: Mar 30, 2021 · Completed: Jul 31, 2026
5 conditions
2 sponsors
3 locations
NCT04766424
Sleep Technology Intervention to Target Cardiometabolic Health
NA
Active, not recruiting
120 participants
Started: Mar 30, 2021 · Completed: Jun 14, 2025
2 conditions
3 sponsors
1 location
NCT04844944
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
N/A
Recruiting
24,000 participants
Started: Mar 30, 2021 · Completed: Mar 1, 2026
3 conditions
1 sponsor
10 locations
NCT06250894
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
PHASE2
Recruiting
32 participants
Started: Mar 30, 2021 · Completed: Mar 30, 2025
3 conditions
1 sponsor
1 location
NCT04431024
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
N/A
Recruiting
800 participants
Started: Mar 30, 2021 · Completed: Jun 30, 2038
4 conditions
1 sponsor
1 location
NCT04715568
Secondhand Tobacco Smoke and Cardiovascular Disease
PHASE4
Recruiting
100 participants
Started: Mar 30, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04708834
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
PHASE3
Enrolling by invitation
1,200 participants
Started: Mar 30, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
175 locations
NCT04840472
Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
PHASE1
Recruiting
28 participants
Started: Mar 30, 2021 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT04786223
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia
PHASE2
Enrolling by invitation
100 participants
Started: Mar 30, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT04762758
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
PHASE3
Active, not recruiting
350 participants
Started: Mar 30, 2021 · Completed: Apr 19, 2024
1 condition
2 sponsors
50 locations
NCT04513223
A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors
PHASE1
Active, not recruiting
101 participants
Started: Mar 30, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04472845
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).
NA
Recruiting
1,018 participants
Started: Mar 30, 2021 · Completed: Aug 20, 2028
3 conditions
1 sponsor
1 location
NCT04727489
Study of the Genetic Factors Involved in Autism and Related Disorders
N/A
Recruiting
3,800 participants
Started: Mar 30, 2021 · Completed: Mar 31, 2036
1 condition
1 sponsor
6 locations
NCT04871282
A Study of AL102 in Patients With Progressing Desmoid Tumors
PHASE2/PHASE3
Active, not recruiting
198 participants
Started: Mar 30, 2021 · Completed: Oct 31, 2026
2 conditions
1 sponsor
53 locations
NCT05013333
AED 3 Post-Approval Study
NA
Active, not recruiting
38 participants
Started: Mar 30, 2021 · Completed: Feb 28, 2029
1 condition
1 sponsor
2 locations
NCT04754581
Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes
NA
Recruiting
12 participants
Started: Mar 30, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05809635
Study of BEST1 Vitelliform Macular Dystrophy
N/A
Recruiting
52 participants
Started: Mar 30, 2021 · Completed: May 31, 2026
2 conditions
4 sponsors
3 locations
NCT04703686
Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
PHASE2
Active, not recruiting
67 participants
Started: Mar 30, 2021 · Completed: Mar 1, 2026
5 conditions
1 sponsor
15 locations
NCT04484142
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
PHASE2
Active, not recruiting
137 participants
Started: Mar 30, 2021 · Completed: Dec 12, 2025
1 condition
2 sponsors
84 locations
NCT04600362
Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
PHASE2
Active, not recruiting
70 participants
Started: Mar 30, 2021 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT04790175
Samsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in SIADH
N/A
Recruiting
300 participants
Started: Mar 29, 2021 · Completed: Jan 31, 2030
1 condition
1 sponsor
1 location
NCT04774705
Effectiveness of Non-invasive Vagus Nerve Stimulation as an Adjuvant Treatment in Patients With Sepsis in Intensive Care.
NA
Recruiting
30 participants
Started: Mar 29, 2021 · Completed: Mar 29, 2025
2 conditions
1 sponsor
1 location
NCT04432636
Gut Bacteria and Brain of the Baby
NA
Recruiting
200 participants
Started: Mar 29, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT04474847
Abatacept for the Treatment of Giant Cell Arteritis
PHASE3
Recruiting
78 participants
Started: Mar 29, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
8 locations
NCT04696029
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
PHASE2
Recruiting
118 participants
Started: Mar 29, 2021 · Completed: Mar 31, 2029
1 condition
1 sponsor
15 locations
NCT04673617
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
45 participants
Started: Mar 29, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
21 locations
NCT05245136
Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
N/A
Recruiting
3,000 participants
Started: Mar 29, 2021 · Completed: Apr 30, 2025
3 conditions
1 sponsor
1 location
NCT04704986
Comparison of PolarX and the Arctic Front Cryoballoons for PVI in Patients With Symptomatic Paroxysmal AF
PHASE4
Active, not recruiting
201 participants
Started: Mar 29, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
2 locations
NCT05434312
TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
PHASE1
Active, not recruiting
90 participants
Started: Mar 29, 2021 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06335030
Sensory and Behavioral Aspects With Particular Attention to Food Selectivity in Children With Autism
N/A
Recruiting
50 participants
Started: Mar 29, 2021 · Completed: Nov 30, 2024
1 condition
3 sponsors
3 locations
NCT04673942
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
PHASE2
Recruiting
140 participants
Started: Mar 29, 2021 · Completed: Mar 1, 2027
6 conditions
1 sponsor
6 locations
NCT04674969
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
N/A
Recruiting
5,000 participants
Started: Mar 29, 2021 · Completed: Jan 31, 2028
1 condition
1 sponsor
79 locations
NCT04786262
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
PHASE3
Recruiting
52 participants
Started: Mar 29, 2021 · Completed: Jun 30, 2030
3 conditions
1 sponsor
29 locations
NCT04650919
Aortic Laryngeal Rehabilitation Graft
NA
Recruiting
4 participants
Started: Mar 29, 2021 · Completed: Jul 28, 2026
2 conditions
2 sponsors
1 location
NCT04482660
Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population
NA
Enrolling by invitation
100 participants
Started: Mar 29, 2021 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT06027645
Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder
NA
Recruiting
50 participants
Started: Mar 29, 2021 · Completed: Dec 31, 2029
5 conditions
5 sponsors
3 locations
NCT04785287
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Mar 29, 2021 · Completed: May 27, 2027
17 conditions
1 sponsor
1 location
NCT04533217
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
NA
Recruiting
90 participants
Started: Mar 29, 2021 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT04523922
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
PHASE2
Active, not recruiting
180 participants
Started: Mar 29, 2021 · Completed: Jan 1, 2026
2 conditions
2 sponsors
1 location
NCT04824443
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
PHASE1
Active, not recruiting
3 participants
Started: Mar 29, 2021 · Completed: Mar 29, 2026
3 conditions
1 sponsor
7 locations
NCT05084352
Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury
N/A
Recruiting
1,200 participants
Started: Mar 29, 2021 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
1943
1944
1945
1946
1947
1948
1949
More pages
2369
Next